Kibow Biotech Inc.
Records under this name other than the patents Kibow Biotech Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,980,988 | Compositions and methods for augmenting kidney function Term ended Term ended Mar 21, 2025 · USPTO record | Term ended | Term ended Mar 21, 2025 | USPTO record |
| US 11,103,542 | Composition and method for maintaining healthy kidney function Term ended Term ended Jan 18, 2024 · USPTO record | Term ended | Term ended Jan 18, 2024 | USPTO record |
| US 8,257,750 | Calcium carbonate compositions for preventing or treating hyperphosphatemia Term ended Term ended Dec 3, 2022 · USPTO record | Term ended | Term ended Dec 3, 2022 | USPTO record |
| US 8,257,693 | Composition for maintaining healthy kidney function Term ended Term ended Mar 13, 2022 · USPTO record | Term ended | Term ended Mar 13, 2022 | USPTO record |
| US 11,179,426 | Composition and method for maintaining healthy kidney function Term ended Ended no later than Mar 13, 2022 · USPTO record | Term ended | Ended no later than Mar 13, 2022 | USPTO record |
| US 6,706,287 | Prebiotic and probiotic compositions and methods for their use in gut-based therapies Term ended Term ended Jan 19, 2022 · USPTO record | Term ended | Term ended Jan 19, 2022 | USPTO record |
| US 8,481,025 | Composition for maintaining healthy kidney function Lapsed on the fee record Ended Jul 9, 2021 · USPTO record | Lapsed on the fee record | Ended Jul 9, 2021 | USPTO record |
| US 9,655,932 | Composition and method for preventing or treating gout or hyperuricemia Lapsed on the fee record Ended May 23, 2021 · USPTO record | Lapsed on the fee record | Ended May 23, 2021 | USPTO record |
| US 7,998,470 | Compositions and methods improving renal function Term ended Term ended Oct 27, 2020 · USPTO record | Term ended | Term ended Oct 27, 2020 | USPTO record |
| US 7,026,160 | Oral bacteriotherapy compositions and methods Term ended Term ended May 27, 2020 · USPTO record | Term ended | Term ended May 27, 2020 | USPTO record |